Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453270 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453266 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453271 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453272 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453273 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453274 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453216 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-isobu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453216 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-isobu...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453217 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453218 (US10729691, Example 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453221 (US10729691, Example 6) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453222 (US10729691, Example 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453222 (US10729691, Example 7) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453227 (US10729691, Example 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453228 (US10729691, Example 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453231 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453233 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453234 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453235 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453236 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453241 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453242 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453242 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453243 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453243 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453244 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453245 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453246 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453253 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-methy...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453255 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453255 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453256 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453256 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453258 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)thieno[3...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453259 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453260 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453260 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453261 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453261 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453262 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453263 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453263 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453264 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453264 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453265 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453265 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453267 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453268 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 2, facilitated glucose transporter member 1 (Homo sapiens (Human)) | BDBM453262 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Putative sugar transporter (Plasmodium falciparum) | BDBM453270 (2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...) | PDB KEGG UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
KADMON CORPORATION, LLC US Patent | Assay Description Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t... | US Patent US10729691 (2020) BindingDB Entry DOI: 10.7270/Q2417142 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 118 total ) | Next | Last >> |